For millions of women, the onset of perimenopause and menopause is a clinical desert. Symptoms like hot flashes, sleep disruption, and mood changes are often dismissed or met with fragmented, hard-to-access care. Evernow, a virtual care platform founded in 2019, is betting that a subscription model with 24/7 access to menopause-certified clinicians can finally map a consistent path through it [PERPLEXITY SONAR PRO BRIEF]. The company has raised over $52.5 million, including a $28.5 million Series A led by New Enterprise Associates, to build what it calls an all-inclusive healthcare service for women over 40 [Fierce Healthcare, May 2022] [AngelList].
A DARPA veteran's pivot to patient care
Founder and CEO Dr. Alicia Jackson brings an unconventional background to the healthtech space. She holds a PhD in engineering from MIT and previously served as Deputy Director of the Biological Technologies Office at DARPA, overseeing advanced biotech programs [PERPLEXITY SONAR PRO BRIEF]. Her pivot from defense research to direct patient care is a deliberate one, aimed at applying systems-level thinking to a neglected area of medicine. Jackson has also been appointed Director of the Advanced Research Projects Agency for Health (ARPA-H), a role she assumed in October 2025 [POLITICO, October 2025]. This dual position underscores a unique profile, bridging high-level biomedical innovation policy with the operational demands of running a venture-backed telehealth company.
The evidence-based, all-access wedge
Evernow's clinical approach is its primary differentiator in a growing field of digital menopause services. The company emphasizes that its care is evidence-based and safety-oriented, offering both hormone therapy (HT) and non-hormonal options after individualized risk assessments [PERPLEXITY SONAR PRO BRIEF]. Its internal studies claim significant results, including a massive decrease in symptom severity for patients using menopausal hormone therapy [katiecouric.com]. The service model is built on unlimited access. For a membership fee starting at $49 per month, patients get a personalized care plan, medication management, and 24/7 messaging support with clinicians, circumventing the typical wait times for an OB-GYN appointment [USA Today, February 2024] [PERPLEXITY SONAR PRO BRIEF].
Series A (2022) | 28.5 | M USD
Total Disclosed Funding | 52.5 | M USD
The go-to-market strategy leans heavily on direct-to-consumer subscription fees, but the company has signaled a move toward broader access. A strategic partnership with Talkspace, a teletherapy platform, aims to enhance integrated mental health support for a population of approximately 113 million lives [Private candid take]. This suggests an early play for embedded, B2B2C distribution beyond pure out-of-pocket payments.
Navigating a competitive and regulated landscape
The market for digital menopause care is becoming crowded, with players like Midi Health, Gennev, and Alloy also vying for patients. Evernow's bet rests on a combination of clinical rigor, always-on access, and brand visibility. Its roster of celebrity investors, including Gwyneth Paltrow, Drew Barrymore, and Cameron Diaz, has provided cultural cachet and helped destigmatize the conversation around menopause [The Information, May 2022]. However, the competitive pressures are real. Success will depend on demonstrating superior patient outcomes and retention at scale, metrics that remain closely held by the company.
The regulatory context is another critical factor. While the service is virtual, the prescriptions it manages,particularly hormone therapies,are serious medications. Evernow's emphasis on being "safety-oriented" is a necessary stance in a category where treatment decisions carry long-term health implications [PERPLEXITY SONAR PRO BRIEF]. The company's ability to maintain rigorous clinical protocols and transparent outcome reporting as it scales will be a key marker of its sustainability.
The patient population and the standard of care
The disease state here is the menopausal transition, encompassing perimenopause and menopause, affecting women typically over the age of 40. The patient population is vast, historically underserved, and often spends years navigating a patchwork of general practitioners, gynecologists, and online forums without a coordinated care plan. Symptoms are not trivial; they range from vasomotor disturbances like hot flashes and night sweats to psychological effects like anxiety and cognitive changes, all of which can significantly impair quality of life.
The standard of care today is fragmented and often inaccessible. Many women report that their concerns are minimized during primary care visits. Access to a menopause specialist can involve long wait times, geographic limitations, and lack of insurance coverage. Treatment options, when discussed, may not be presented in a comprehensive, evidence-based manner. This gap between the prevalence of symptoms and the availability of informed, consistent care is the core problem Evernow is attempting to solve with its virtual, specialist-led model.
What to watch in the next twelve months
The coming year will test several facets of Evernow's model. The operational balance for founder Alicia Jackson, who leads both Evernow and ARPA-H, will be closely watched. Clinically, the publication of peer-reviewed data from its internal studies would provide valuable external validation for its evidence-based claims. Commercially, the expansion of the Talkspace partnership and the pursuit of additional employer or payer contracts will indicate whether the company can move beyond a purely DTC model to achieve wider population reach. Finally, in a competitive market, Evernow's ability to convert its brand visibility and clinician access into durable patient relationships will define its next chapter.
Sources
- [Fierce Healthcare, May 2022] Telehealth startup Evernow lands $28.5M series A for menopause treatments | https://www.fiercehealthcare.com/health-tech/telehealth-startup-evernow-lands-285m-series-menopause-treatments-247-medical-support
- [AngelList] Evernow funding overview | https://angel.co/company/evernow
- [USA Today, February 2024] Evernow membership pricing and service details | https://www.usatoday.com/money/blueprint/health/evernow-review/
- [katiecouric.com] Evernow study on menopause symptom reduction | https://katiecouric.com/health/evernow-menopause-study-results/
- [The Information, May 2022] Celebrity backing and market context | https://www.theinformation.com/articles/making-it-cool-to-talk-about-menopause-a-celebrity-backed-startup-taps-a-long-neglected-market
- [POLITICO, October 2025] Appointment of Dr. Alicia Jackson as ARPA-H Director | https://www.politico.com/news/2025/10/20/alicia-jackson-arpa-h-director-00172812